prolonged-release oral fampridine in Neuromyelitis Optica (NMO), Pilot feasibility Study
- Registry ID
- EUCTR2013-000529-30
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE4
- Sponsor
- Walton Centre Foundation Trust
- Start date
- 2013-11-27
- Completion date
- 2015-03-04
- Last update
- 2026-08-16
Conditions
- Neuromyelitis optica (NMO)
Summary
Does Fampridine-PR improve walking speed in a group of patients with ambulatory deficits due to Neuromyelitis Optica (NMO)?
Locations
View on source registry